Whole-body periodic acceleration modifies experimental asthma in sheep

American Journal of Respiratory and Critical Care Medicine

Volumn 174, Issue 7, 2006, Pages 743-752

  Abraham, William M ^a   Ahmed, Ashfaq ^b   Serebriakov, Irakli ^b   Lauredo, Isabel T ^b   Bassuk, Jorge ^b   Adams, Jose A ^b   Sackner, Marvin A ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

Animal models; Asthma therapy; Nitric oxide; Noninvasive periodic acceleration

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N(G) NITROARGININE; NITRIC OXIDE;

AIRWAY; AIRWAY RESISTANCE; ALLERGY TEST; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCARIS SUUM; ASTHMA; CONTROLLED STUDY; ENDOTHELIUM; EXPERIMENTAL DESIGN; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PULSATILE FLOW; RESUSCITATION; SHEAR STRESS; SHEEP; WHOLE BODY COUNTING;

ACCELERATION; ANIMALS; ANTIGENS, HELMINTH; ASCARIS SUUM; ASTHMA; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; NF-KAPPA B; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; SHEEP; STRESS, MECHANICAL;

EID: 33749451807     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200601-048OC     Document Type: Article

References (63)

1. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004;84:731-765.
2. Van Overveld FJ, Bult H, Vermeire PA, Herman AG. Nitroprusside, a nitrogen oxide generating drug, inhibits release of histamine and tryptase from human skin mast cells. Agents Actions 1993;38:C237-C238.
3. Coleman JW. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol 2002;129:4-10.
4. Davis BJ, Flanagan BF, Gilfillan AM, Metcalfe DD, Coleman JW. Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells. J Immunol 2004;173:6914-6920.
5. Gaboury JP, Niu XF, Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 1996;93:318-326.
6. D'Acquisto F, May MJ, Ghosh S. Inhibition of nuclear factor Kappa B (NF-B): an emerging theme in anti-inflammatory therapies. Mol Interv 2002;2:22-35.
7. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260.
8. Peng HB, Libby P, Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995;270:14214-14219.
9. Colasanti M, Persichini T, Menegazzi M, Mariotto S, Giordano E, Caldarera CM, Sogos V, Lauro GM, Suzuki H. Induction of nitric oxide synthase mRNAexpression: suppression by exogenous nitric oxide. J Biol Chem 1995;270:26731-26733.
10. Park SK, Lin HL, Murphy S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. Biochem J 1997;322:609-613.
11. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999;54:825-857.
12. Taylor DA, McGrath JL, O'Connor BJ, Barnes PJ. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide. Am J Respir Crit Care Med 1998;158:99-106.
13. Ten Broeke R, De CR, Van HR, Verweij V, Leusink-Muis T, Van Ark I, De Clerck F, Nijkamp FP, Folkerts G. Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir Res 2006;7:58.
14. Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am J Physiol Cell Physiol 2003;285:C499-C508.
15. Adams JA, Moore JE Jr, Moreno MR, Coelho J, Bassuk J, Wu D. Effects of periodic body acceleration on the in vivo vasoactive response to N-omega-nitro-L-arginine and the in vitro nitric oxide production. Ann Biomed Eng 2003;31:1337-1346.
16. Hutcheson IR, Griffith TM. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. Am J Physiol 1991;261:H257-H262.
17. Adams JA, Mangino MJ, Bassuk J, Sackner MA. Hemodynamic effects of periodic G(z) acceleration in meconium aspiration in pigs. J Appl Physiol 2000;89:2447-2452.
18. Adams JA, Mangino MJ, Bassuk J, Inman DM, Sackner MA. Noninvasive motion ventilation (NIMV): a novel approach to ventilatory support. J Appl Physiol 2000;89:2438-2446.
19. Sackner MA, Gummels E, Adams JA. Effect of moderate-intensity exercise, whole-body periodic acceleration, and passive cycling on nitric oxide release into circulation. Chest 2005;128:2794-2803.
20. Sackner MA, Gummels E, Adams JA. Nitric oxide is released into circulation with whole-body, periodic acceleration. Chest 2005;127:30-39.
21. Sackner MA, Gummels EM, Adams JA. Say NO to fibromyalgia and chronic fatigue syndrome: an alternative and complementary therapy to aerobic exercise. Med Hypotheses 2004;63:118-123.
22. Adams JA, Bassuk J, Wu D, Grana M, Kurlansky P, Sackner MA. Periodic acceleration: effects on vasoactive, fibrinolytic, and coagulation factors. J Appl Physiol 2005;98:1083-1090.
23. Adams JA, Mangino MJ, Bassuk J, Kurlansky P, Sackner MA. Novel CPR with periodic Gz acceleration. Resuscitation 2001;51:55-62.
24. Adams JA, Bassuk J, Wu D, Kurlansky P. Survival and normal neurological outcome after CPR with periodic Gz acceleration and vasopressin. Resuscitation 2003;56:215-221.
25. Trochu JN, Bouhour JB, Kaley G, Hintze TH. Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease. Circ Res 2000;87:1108-1117.
26. Abraham WM. Animal models of asthma. In: Busse WW, Holgate ST, editors. Asthma & rhinitis. Oxford: Blackwell Science; 2000. pp. 1205-1227.
27. Abraham WM, Ahmed A, Serebriakov I, Bassuk J, Adams JA, Sackner MA. Periodic acceleration via nitric oxide release modifies antigen-induced airway responses in sheep [abstract]. Am J Respir Crit Care Med 2004;169:A321.
28. Sackner MA, Lauredo IT, Serebriakov I, Ahmed A, Adams JA, Bassuk J, Abraham WM. Periodic acceleration modifies antigen-induced airway responses in sheep by nitric oxide (NO)-mediated down regulation of nuclear factor kappa beta (NF-kB) [abstract]. Eur Respir J 2004;24:128s.
29. Abraham WM, Delehunt JC, Yerger L, Marchette B. Characterization of a late phase pulmonary response following antigen challenge in allergic sheep. Am Rev Respir Dis 1983;128:839-844.
30. Abraham WM, Gill A, Ahmed A, Sielczak MW, Lauredo IT, Botvinnikova Y, Lin KC, Pepinsky B, Leone DR, Lobb RR, et al. A small-molecule, tight binding inhibitor of the integrin α(4)β(1) blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am J Respir Crit Care Med 2000;162:603-611.
31. Abraham WM, Sielczak MW, Ahmed A, Cortes A, Lauredo IT, Kim J, Pepinsky B, Benjamin CD, Leone DR, Lobb RR, et al. Alpha4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 1994;93:776-787.
32. Abraham WM, Ahmed A, Sabater JR, Lauredo IT, Botvinnikova Y, Bjercke RJ, Hu X, Revelle BM, Kogan TP, Scott IL, et al. Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med 1999;159:1205-1214.
33. Hinder F, Meyer J, Booke M, Ehardt JS, Salsbury JR, Traber LD, Traber DL. Endogenous nitric oxide and the pulmonary microvasculature in healthy sheep and during systemic inflammation. Am J Respir Crit Care Med 1998;157:1542-1549.
34. Apple JK, Minton JE, Parsons KM, Unruh JA. Influence of repeated restraint and isolation stress and electrolyte administration on pituitary-adrenal secretions, electrolytes, and other blood constituents of sheep. J Anim Sci 1993;71:71-77.
35. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, Kelm M. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA 2001;98:12814-12819.
36. Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TL, Gosling RG, Ritter JM, Anggard EE. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 1999;34:2007-2014.
37. Lund F. Digital pulse plethysmography (DPG) in studies of the hemodynamic response to nitrates: a survey of recording methods and principles of analysis. Acta Pharmacol Toxicol (Copenh) 1986;59:79-96.
38. Trifilieff A, Fujitani Y, Mentz F, Dugas B, Fuentes M, Bertrand C. Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol 2000;165:1526-1533.
39. Brown RH, Mitzner W. Airway response to deep inspiration: role of nitric oxide. Eur Respir J 2003;22:57-61.
40. Southan GJ, Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996;51:383-394.
41. Abraham WM, Burch RM, Farmer SG, Sielczak MW, Ahmed A, Cortes A. A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep. Am Rev Respir Dis 1991;143:787-796.
42. Clark JM, Abraham WM, Fishman CE, Forteza R, Ahmed A, Cortes A, Warne RL, Moore WR, Tanaka RD. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 1995;152:2076-2083.
43. Ahmed A, D'Brot J, Abraham WM, Lucio J, Mendelssohn R, Robinson MJ, Shakir S, SanPedro B. Heterogeneity of allergic airway responses in sheep: differences in signal transduction? Am J Respir Crit Care Med 1996;154:843-849.
44. Iikura M, Takaishi T, Hirai K, Yamada H, Iida M, Koshino T, Morita Y. Exogenous nitric oxide regulates the degranulation of human basophils and rat peritoneal mast cells. Int Arch Allergy Immunol 1998;115:129-136.
45. Middelveld RJ, Zetterquist WC, Bergman D, Alving K. Nitric oxide synthase inhibition augments acute allergic reactions in the pig airways in vivo. Eur Respir J 2000;16:836-844.
46. Russi EW, Perruchoud AP, Yerger LD, Stevenson JS, Tabak J, Marchette B, Abraham WM. Late phase bronchial obstruction following non-immunologic mast cell degranulation. J Appl Physiol 1984;57:1182-1188.
47. 3-mediated mast cell degranulation. J Appl Physiol 1994;76:893-901.
48. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis 1987;136:740-751.
49. Delehunt JC, Perruchoud AP, Yerger L, Marchette B, Stevenson JS, Abraham WM. The role of SRS-A in the late bronchial response following antigen challenge in allergic sheep. Am Rev Respir Dis 1984;130:748-754.
50. Wright CD, Havill AM, Middleton SC, Kashem MA, Lee PA, Dripps DJ, O'Riordan TG, Bevilacqua MP, Abraham WM. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma. J Pharmacol Exp Ther 1999;289:1007-1014.
51. Abraham WM, Ahmed A, Serebriakov I, Carmillo AN, Ferrant J, de Fougerolles AR, Garber EA, Gotwals PJ, Koteliansky VE, Taylor F, et al. A monoclonal antibody to α1β1 blocks antigen-induced airway responses in sheep. Am J Respir Crit Care Med 2004;169:97-104.
52. Rosen SD, Tsay D, Singer MS, Hemmerich S, Abraham WM. Therapeutic targeting of endothelial ligands for L-selectin (PNAd) in a sheep model of asthma. Am J Pathol 2005;166:935-944.
53. Marshall HE, Stamler JS. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 2001;40:1688-1693.
54. Bantel H, Schmitz ML, Raible A, Gregor M, Schulze-Osthoff K. Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness. FASEB J 2002;16:1832-1834.
55. Gagliardo R, Chanez P, Mathieu M, Bruno A, Costanzo G, Gougat C, Vachier I, Bousquet J, Bonsignore G, Vignola AM. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med 2003;168:1190-1198.
56. Poynter ME, Irvin CG, Janssen-Heininger YMW. Rapid activation of nuclear factor-κB in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol 2002;160:1325-1334.
57. Barnes PJ, Adcock IM. Transcription factors and asthma. Eur Respir J 1998;12:221-234.
58. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2001;2:45-50.
59. Donovan CE, Mark DA, He HZ, Liou HC, Kobzik L, Wang Y, De Sanctis GT, Perkins DL, Finn PW. NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J Immunol 1999;163:6827-6833.
60. Bureau F, Bonizzi G, Kirschvink N, Delhalle S, Desmecht D, Merville MP, Bours V, Lekeux P. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 2000;161:1314-1321.
61. Sandersen C, Bureau F, Turlej R, Fiévez L, Dogné N. p65 homodimer activity in distal airway cells determines lung dysfunction in equine heaves. Vet Immunol Immunopathol 2001;80:315-326.
62. Lobb RR, Abraham WM, Burkly LC, Gill A, Ma W, Knight JA, Leone DR, Antognetti G, Pepinsky RB. Pathophysiologic role of α4 integrins in the lung. Ann N Y Acad Sci 1996;796:113-123.
63. Sasaki H, Yanai M, Shimura S, Okayama H, Aikawa T, Sasaki T, Takishima T. Late asthmatic response to Ascaris antigen challenge in dogs treated with metyrapone. Am Rev Respir Dis 1987;136:1459-1465.